Properties of cell penetrating peptides (CPPs)

IUBMB Life

Volumn 58, Issue 1, 2006, Pages 7-13

  Kerkis, Alexandre ^a   Hayashi, Mirian A F ^b   Yamane, Tetsuo ^c   Kerkis, Irina ^d  

^a Clinica e Centro de Pesquisa em Reproducao Humana Roger Abdelmassih   (Brazil)

^b Laboratório Especial de Toxinologia Aplicada   (Brazil)

^c INSTITUTO DE PESQUISAS ENERGÉTICAS E NUCLEARES   (Brazil)

^d INSTITUTO BUTANTAN   (Brazil)

Author keywords

Cell penetrating peptides; DNA delivery systems

Indexed keywords

CROTAMINE; PEPTIDE;

AMINO ACID SEQUENCE; CELL INTERACTION; CELL PROLIFERATION; CELL SPECIFICITY; CELL STRUCTURE; CELLULAR DISTRIBUTION; CENTRIOLE; CHROMOSOME; CYTOSKELETON; DATA ANALYSIS; GENE DELIVERY SYSTEM; GENE SEQUENCE; GENE TARGETING; GENETIC REGULATION; MACROMOLECULE; NONHUMAN; NONVIRAL GENE THERAPY; PROTEIN INTERACTION; PROTEIN LOCALIZATION; REVIEW; TISSUE SPECIFICITY; VIRUS VECTOR;

CELL MEMBRANE; CELL PROLIFERATION; DRUG DELIVERY SYSTEMS; HUMANS; INTRACELLULAR SPACE; PEPTIDES; PROTEIN TRANSPORT;

EID: 33645104169     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1080/15216540500494508     Document Type: Review

References (79)

1. Fawell, S., Seery, J., Daikh, Y., Moore, C., Chen, L. L., Pepinsky, B., and Barsoum, J. (1994) Tat-mediated delivery of heterologous proteins into cells. Proc. Natl. Acad. Sci. USA 91, 664-668.
2. Vivès, E., Brodin, P., and Lebleu, B. (1997) A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272, 16010-16017.
3. Vivès, E., Granier, C., Prevot, P., and Lebleu, B. (1997) Structure-activity relationship study of the plasma membrane translocating potential of a short peptide from HIV-1 Tat protein. Lett. Pept. Sci. 4, 429-436.
4. Derossi, D., Chassaing, G., and Prochaiantz, A. (1998) Trojan peptides: the penetratin system for intracellular delivery. Trends Cell Biol. 8, 84-87.
5. Schwarze, S. R., Ho, A., Vocero-Akbani, A., and Dowdy, S. F. (1999) In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285, 1569-1572.
6. Caron, N. J., Torrente, Y., Camirand, G., Bujold, M., Chapdelaine, P., Leriche, K., Bresolin, N., and Tremblay, J. P. (2001) Intercellular delivery of a TAt-eGFP fusion protein into muscle cells. Mol. Ther. 3, 310-318.
7. Sadler, K., Eom, K. D., Yang, J. L., Dimitrova, Y., and Tam, J. P. (2002) Translocating proline-rich peptides from the antimicrobial peptide bactenecin 7. Biochemistry 41, 14150-14157.
8. Kobayashi, S., Takeshima, K., Park, C. B., Kim, S. C., and Matsuzaki, K. (2000) Interactions of the novel antimicrobial peptide buforin 2 with lipid bilayers: proline as a translocation promoting factor. Biochemistry 39, 8648-8654.
9. Green, M., and Loewenstein, P. M. (1988) Autonomous functional domain of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell 55, 1179-1188.
10. Frankel, A., and Pabo, C. (1988) Cellular uptake of the tat protein from human immunodeficiency virus. Cell 55, 1189-1193.
11. Derossi, D., Jolito, A. H., Chassaing, G., and Prochiantz, A. (1994) The third helix of the Antennapedia homeodomain translocates through biological membranes. J. Biol. Chem. 269, 10444-10450.
12. Thorén, P. E. G., Persson, D., Karlsson, M., and Nordén, B. (2000) The Antennapedia peptide penetratin translocates across lipid bilayers - the first direct observation. FEBS Lett. 482, 265-268.
13. Elmquist, A., Lindgren, M., Bartfai, T., and Langel, U. (2001) VE-cadherin-derived cell-penetrating peptide, pVEC, with carrier functions. Exp. Cell Res. 269, 237-244.
14. Elliott, G., and O'Hare, P. (1997) Intercellular trafficking and protein delivery by a herpes virus structural protein. Cell 88, 223-233.
15. Phelan, A., Elliot, G., and O'Hare, P. (1998) Intercellular delivery of functional p53 by the herpesvirus protein VP22. Nat. Biotechnol. 16, 440-443.
16. Aints, A., Guven, H., Gahrton, G., Smith, C. I., and Dilber, M. S. (2001) Mapping of herpes simplex virus-1 VP22 functional domains for inter- and subcellular protein targeting. Gene Ther. 8, 1051-1056.
17. Rothbard, J. B., Garlington, S., Lin, Q., Kirschberg, T., Kreider, E., McGrane, P. L., Wender, P. A., and Khavari, P. A. (2000) Conjugation of arginine oligomers to cyclosporine A facilitates topical delivery and inhibition of inflammation. Nat. Med. 6, 1253-1257.
18. Mitchell, D. J, Kim, D. T., Steinman, L., Fathman, C. G., and Rothbard, J. B. (2000) Polyarginine enters cells more efficiently than other polycationic homopolymers. J. Pept. Res. 56, 318-325.
19. Futaki, S., Suzuki, T., Ohashi, W., Yagami, T., Tanaka, S., Ueda, K., and Sugiura, Y. (2001) Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J. Biol Chem. 276, 5836-5840.
20. Futaki, S. (2002) Arginine-rich peptides: potential for intracellular delivery of macromolecules and the mystery of the translocation mechanisms. Int. J. Pharm. 245, 1-7.
21. Oehlke, J., Scheller, A., Wiesner, B., Krause, E., Beyermann, M., Klauschenz, E., Melzig, M., and Bienert, M. (1998) Cellular uptake of an alpha-helical amphipatic model peptide with the potential to deliver polar compounds into the cell interior non-endocytically. Biochim. Biophys. Acta 1414, 127-139.
22. Pooga, M., Hällbrink, M., Zorko, M., and Langel, U. (1998) Cell penetration by transportan. FASEB J. 12, 67-77.
23. Pooga, M., Lindgren, M., Hallbrink, M., Brakenhielm, E., and Langel, U. (1998) Galanin-based peptides, galparan and transportan, with receptor-dependent and independent activities. Ann. NY Acad. Sci. 863, 450-453.
24. Suzuki, T., et al., (2002) Possible existence of common internalization mechanisms among arginine-rich peptides. J. Biol. Chem. 277, 2437-2443.
25. Kalderon, D., Roberts, B. L., Richardson, W. D., and Smith, A. E. (1984) A short amino acid sequence able to specify nuclear location. Cell 39, 499-509.
26. Hawiger, J. (1999) Noninvasive intracellular delivery of functional peptides and proteins. Curr. Opin. Chem. Biol. 3, 89-94.
27. Schwarze, S. R., Hruska, K. A., and Dowdy, S. F. (2000) Protein transduction: unrestricted delivery into the cells? Trends Cell Biol. 10, 290-296.
28. Morris, M. C., Chaloin, L., Heitz, F., and Divita, G. (2000) Translocating peptides and proteins and their use for gene delivery. Curr. Opin. Biotechnol. 11, 461-466.
29. Cashman, S. M., Sadowski, S. L., Morris, D. J., Frederick, J., and Kumar-Singh, R. (2002) Intercellular trafficking of adenovirus-delivered HSV VP22 from the retinal pigment epithelium to the photoreceptor-Implication for gene therapy. Mol. Ther. 6, 813-823.
30. Ford, K. G., Darling, D., Souberbielle, B., and Farzaneh, F. (2000) Protein transduction: a new tool for the study of cellular ageing and senescence. Mech. Ageing Dev. 121, 113-121.
31. Peitz, M., Pfannkuche, K., Rajewsky, K., and Edenhofer, F. (2002) Ability of the hydrophobic FGF and basic TAT peptides to promote cellular uptake of recombinant Cre recombinase: A tool for efficient genetic engineering of mammalian genomes. Proc. Natl. Acad. Sci. USA 99, 4489-4494.
32. Lundberg, P., and Langel, U. (2003) A brief introduction to cell-penetrating peptides. J. Mol. Recognit. 16, 227-233.
33. Kabouridis, P. S. (2003) Biological applications of protein transduction technology. Trends Biotechnol. 21, 498-503.
34. Zhao, M., and Weissleder, R. (2004) Intracellular cargo delivery using tat peptide and derivatives. Med. Res. Rev. 24, 1-12.
35. Jarver, P., and Langel, U. (2004) The use of cell-penetrating peptides as a tool for gene regulation. Drug Discov. Today 9, 395-402.
36. Kerkis, A., Kerkis, I., Rádis-Baptista, G., Oliveira, E. B., Vianna-Morgante, A. M., Pereira, L. V., and Yamane, T. (2004) Crotamine is a novel cell-penetrating protein from the venom of rattlesnake Crotalus durissus terrificus. FASEB J. 18, 1407-1409.
37. Fernandez-Carneado, J., Kogan, M. J., Pujals, S., and Giralt, E. (2004) Amphipatic peptides and drug delivery. Biopolymers 76, 196-203.
38. Lundberg, M., and Johansson, M. (2001) Is VP22 nuclear homing an artifact? Nat. Biotechnol. 19, 713.
39. Lundberg, M., and Johansson, M. (2002) Positively charged DNA-binding proteins cause apparent cell membrane translocation. Biochem. Biophys. Res. Commun. 291, 367-371.
40. Richard, J. P., Melikov, K., Vives, E., Ramos, C., Verbeure, B., Gait, M. J., Chernomordik, L. V., and Lebleu, B. (2003) Cell-penetrating peptides. A re-evaluation of the mechanisms of cellular uptake. J. Biol. Chem. 278, 585-590.
41. Krämer, S. D., and Wunderli-Allenspach, H. (2003) No entry for TAT(44-57) into liposomes and intact MDCK cells: novel approach to study membrane permeation of cell-penetrating peptides. Biochim. Biophys. Acta 1609, 161-169.
42. Drin, G., Cottin, S., Blanc, E., Rees, A. R., and Temsamani, J. (2003) Studies on the internalization mechanism of cationic cell-penetrating peptides. J. Biol. Chem. 278, 31192-31201.
43. Fischer, R., Köhler, K., Fotin-Mleczek, M., and Brock, R. (2004) A stepwise dissection of the intracellular fate of cationic cell-penetrating peptides. J. Biol. Chem. 279, 12625-12635.
44. Thorén, P. E. G., Persson, D., Isakson, P., Goksör, M, Önfelt, A., and Nordén, B. (2003) Uptake analogs of penetratin, Tat(48-60) and oligoarginine in live cells. Biochem. Biophys. Res. Commun. 307, 100-107.
45. TAT derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: optical, biophysical, and metabolic evidence. Biochemistry 44, 138-148.
46. Mi, Z., Mai, J., Lu, X., and Robbins, P. D. (2000) Characterization of class of cationic peptides able to facilitate efficient protein transduction in vitro and in vivo. Mol. Therapy 4, 339-347.
47. Shen, W. C., and Ryser, H. J. (1978) Conjugation of poly-L-lysine to albumin and horseradish peroxidase: A novel method of enhancing the cellular uptake of proteins. Proc. Natl. Acad. Sci. USA 75, 1872-1876.
48. Lindgren, M. Hallbrink, M., Prochiantz, A., and Langel, U. (2000) Cell-penetrating peptides. Trends Pharmacol. Sci. 21, 99-103.
49. Potocky, T. B., Kohler, K., Fotin-Mleczei, M., and Brock, R. (2004) A stepwise dissection of the intracellular fate of cationic cell-penetrating peptides. J. Biol. Chem. 279, 12625-12635.
50. Gupta, B., Levchenko, T. S., and Torchilin, V. P. (2005) Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides. Adv. Drug Deliv. Rev. 57, 637-651.
51. Elliott, G., and O'Hare, P. (2000) Cytoplasm-to-nucleus translocation of a herpesvirus tegument protein during cell division. J. Virol. 74, 2131-2141.
52. Martin, A., O'Hare, P., McLauchlan, J., and Elliott, G. (2002) Herpes simple's virus tegument protein VP22 contains overlapping domains for cytoplasmic localization, microtubule interaction, and chromatin binding. J. Virol. 76, 4961-4970.
53. Lee, C., and Brandt, R. (1992) Microtubule-binding studies revisited: is there a role for MAPs. Trends Cell Biol. 2, 286-489.
54. Zorko, M., and Langel, U. (2005) Cell-penetrating peptides: mechanism and kinetics of cargo delivery. Adv. Drug Deliv. Rev. 57, 529-545.
55. Schwarze, S. R., and Dowdy, S. F. (2000) In vivo protein transduction: intracellular delivery of biologically active proteins, compounds and DNA. Trends Pharmacol. 21, 45-48.
56. Lindsay, M. A. (2002) Peptide-mediated cell delivery: application in protein target validation. Curr. Opin. Pharmacol. 2, 587-594.
57. Roussele, C., Clair, P., Temsamani, J., and Scherrmann, J. M. (2002) Improved brain delivery of benzylpenicillin with a peptide-vector-mediated strategy. J. Drug Target 10, 309-315.
58. Temsamani, J., and Vidal, P. (2004) The use of cell-penetrating peptides for drug delivery. Drug Discov. Today 9, 1012-1019.
59. Lochmann, D., Jauk, E., and Zimmer, A. (2004) Drug delivery of oligonucleotides by peptides. Eur. J. Pharmacol. Biopharm. 58, 237-251.
60. Wadia, J. S., and Dowdy, S. F. (2005) Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer. Adv. Drug Deliv. Rev. 57, 579-596.
61. Hällbrink, M., Florén, A., Elmquist, A., Pooga, M., Bartfai, T., and Langel, U. (2001) Cargo delivery kinetics of cell-penetrating peptides. Biochim. Biophys. Acta 1515, 101-109.
62. Säälik, P., Elmiquist, A., Hansen, M., Padari, K., Saar, K., Viht, K., Langel, U., and Pooga, M. (2004) Protein cargo delivery properties of cell-penetrating peptides. A comparative study. Bioconjugate Chem. 15, 1246-1253.
63. Maiolo, J. R., Ferrer, M., and Ottinger, E. A. (2005) Effects of cargo molecules on the cellular uptake of arginine-rich cell-penetrating peptides. Biochim. Biophys. Acta 1712, 161-172.
64. kip1 induces cell migration. Nat. Med. 4, 1449-1452.
65. Schutze-Redelmeier, M. P., et al., (1996) Introduction of exogenous antigens into the MHC class I processing and presentation pathway by Drosophila Antennapedia homeodomain primers cytotoxic T cells in vivo. J. Immunol. 157, 650-655.
66. Chellaiah M. A., et al., (2000). Rho-A is critical for osteoclast podosome organization, motility and bone resorption. J. Biol. Chem. 275, 11993-12002.
67. Derer, W., Easwaran, H. P., Leonhardt, H., and Cardoso, M. C. (2001) A novel approach to induce cell cycle reentry in terminally differentiated muscle cells. FASEB J. 16, 132-133.
68. Yoon, H-Y., Lee, S. H., Cho, S. W., Lee, J. E., Yoon, C. S., Park, J., Kim, T. U., and Choi, S. Y. (2002). TAT-mediated delivery of human glutamate dehydrogenase into PC12 cells. Neurochem. Int. 41, 37-42.
69. Gratton, J. P., Yu, J., Griffith, J. W., Babbitt, R. W., Scotland, R. S., Hickey, R., Giordano, F. J., and Sessa, W. C. (2003) Cell-permeable peptides improve cellular uptake and therapeutic gene delivery of replication-deficient viruses in cells and in vivo. Nat. Med. 9, 357-362.
70. Thorén, P. E. G., Persson, D., Esbjörner, E. K., Goksör, M., Lincoln, P., and Nordén, B. (2004) Membrane binding and translocation of cell-penetrating peptides. Biochemistry 43, 3471-3489.
71. Herbig, M. E., Fromm, U., Leuenberger, J., Krauss, U., Beck-Sickinger, A. G., and Merkle, H. P. (2005) Bilayer interaction and localization of cell penetrating peptides with model membranes: A comparative study of a human calcitonin (hCT)-derived peptide with pVEC and pAntp(43-58). Biochim. Biophys. Acta 1712, 197-211.
72. Olsnes, S., Klingenberg, O., and Wiedlocha, A. (2003) Transport of exogenous growth factors and cytokines to the cytosol and to the nucleus. Physiol. Rev. 83, 163-182.
73. Wender, P. A., Mitchell, D. J., Pattabiraman, K., Pelkey, E. T., Steinman, L., and Rothbard, J. B. (2000) The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptide molecular transporters. Proc. Natl. Acad. Sci. USA 97, 13003-13008.
74. Foerg, C., Ziegler, U., Fernandez-Carneado, J., Giralt, E., Rennert, R., Beck-Sickinger, A.G., and Merkle, H. P. (2005) Decoding the entry of two novel cell-penetrating peptides in HeLa cells: lipid raft-mediated endocytosis and endosomal escape. Biochemistry 44, 72-81.
75. Jones, S. W., Christison, R., Bundell, K., Voyce, C. J., Brockbank, S. M. V., Newham, P., and Lindsay, M. A. (2005) Characterization of cell-penetrating peptide-mediated peptide delivery. Br. J. Pharmacol. 145, 1093-1102.
76. Henriques, S. T., Costa, J., and Castanho, M. A. R. B. (2005) Translocation of β-galactosidade mediated by the cell-penetrating peptide pep-1 into the lipid vesicles and human HeLa cells is driven by membrane electrostatic potential. Biochemistry 44, 10189-10198.
77. Nir, S., and Nieva, J. L. (2000) Interactions of peptides with liposomes: pore formation and fusion. Prog. Lipid Res. 39, 181-206.
78. Gonçalves, E., Kitas, E., and Seelig, J. (2005) Binding of oligoarginine to membrane lipids and heparan sulfate: structural and thermodynamic characterization of a cell-penetrating peptide. Biochemistry 44, 2692-2702.
79. Park, C. B., Yi, K. S., Matsuzaki, K., Kim, M. S., and Kim, S. C. (2000) Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: The proline hinge is responsible for the cell-penetrating ability of buforin II. Proc. Natl. Acad. Sci. USA 97, 8245-8250.